Articles in Journal
2022
Lederer C.W, Koniali L, Buerki-Thurnherr T, Papasavva P.L, La Grutta S, Licari A, Staud F, Bonifazi D, Kleanthous M.
Pharmaceutics 2022, 14, 793. doi.org/10.3390/
2021
Medical Device Development for Children and Young People—Reviewing the Challenges and Opportunities
P. Dimitri, V. Pignataro, M. Lupo, D. Bonifazi , M. Henke , U. M. Musazzi, F. Ernst, P. Minghetti, D. F. Redaelli, S. G. Antimisiaris, G. Migliaccio, F. Bonifazi, L. Marciani, A. J. Courtenay, N. Denora, A. Lopedota
Pharmaceutics 2021, 13(12), 2178; https://doi.org/10.3390/pharmaceutics13122178
________________
The GluN2B-Selective Antagonist Ro 25-6981 Is Effective
P. Mareš, L. Kozlová , A. Mikulecká, H. Kubová
Pharmaceutics 2021, 13, 1482; https://doi.org/10.3390/pharmaceutics13091482
________________
Children’s Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure)
E. Alessandrini, F. Brako, M. Scarpa, M. Lupo , D. Bonifazi, V. Pignataro, M. Cavallo, O. Cullufe, C. Enache, B. Nafria, J. Claverol, L. De Taeye, E. Vermeulen, J. Preston, C. Tuleu
Pharmaceutics 2021, 13, 730; https://doi.org/10.3390/pharmaceutics13050730
Detection of Breathing Movements of Preterm Neonates by Recording Their Abdominal Movements with a Time-of-Flight Camera
F. C. Wiegandt, D. Biegger , J. F. Fast, G. Matusiak, J. Mazela, T. Ortmaier, T. Doll, A. Dietzel, B. Bohnhorst, G. Pohlmann
Pharmaceutics 2021, 13, 721; https://doi.org/10.3390/pharmaceutics13050721
________________
Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
B. Aurich, E. Jacqz-Aigrain
Pharmaceutics 2021, 13, 695; https://doi.org/10.3390/pharmaceutics13050695
________________
Breath-Triggered Drug Release System for Preterm Neonates
F. C. Wiegandt, U. P. Froriep, F. Müller, T. Doll, A. Dietzel, G. Pohlmann
Pharmaceutics 2021, 13, 657; https://doi.org/10.3390/pharmaceutics13050657
________________
Human Microbiome in Children, at the Crossroad of Social Determinants of Health and Personalized Medicine
Talía Sainz, Valeria Pignataro, Donato Bonifazi, Simona Ravera, María José Mellado, Antonio Pérez-Martínez , Adela Escudero, Adriana Ceci and Cristina Calvo
Children 2021, 8, 1191; https://doi.org/10.3390/children8121191
________________
The Neonatal and Juvenile Pig in Pediatric Drug Discovery and Development
M. Ayuso, L. Buyssens, M. Stroe, A. Valenzuela, K. Allegaert, A. Smits, P. Annaert, A. Mulder, S. Carpentier, C. Van Ginneken, S. Van Cruchten
Pharmaceutics 2021, 13/3; doi: 10.3390/pharmaceutics13030415
________________
Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges
C. Villa, R. Combi, D. Conconi, M. Lavitrano
Pharmaceutics 2021, 13/2; doi: 10.3390/pharmaceutics13020280
________________
2020
Ethical, Legal and Regulatory Issues of Paediatric Translational Research. Call for an Adequate Model of Governance
A. Altavilla, V. Giannuzzi, M. Lupo, D. Bonifazi, A. Ceci
European Journal of Health Law 2020, May 18; doi: 10.1163/15718093-bja10010
________________
Pediatric Biobanking: Kids Are Not Just Little Adults
D. R. Catchpoole, D. Carpentieri, S. Vercauteren, L. Wadhwa, W. Schleif, L. Zhou, J. Zhou, R. M. Labib, E. Smits, E. H. Conradie
Biopreservation and Biobanking 18/4, 2020, August; doi: 10.1089/bio.2020.29071.djc
________________
Chapter in book
Challenges and New Frontiers in the Paediatric Drug Discovery and Development
A. Intini, D. Bonifazi, G. Migliaccio
Drug Discovery and Development – New Advances, 2019; 10.5772/intechopen.85635